Glaxosmithkline PLC, Insider at ChemoCentryx, Inc. (CCXI), sold 14,686,984 shares at $11.69 ($171.7M) on 2018-10-16, disclosed to the SEC on 2018-10-18.
Open-market sale of $171.7M CCXI by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.69 | 7,343,492 | $85.8M | 50.0% |
| 2 | $11.69 | 7,343,492 | $85.8M | 50.0% |
| Total | $11.69 avg | 14,686,984 | $171.7M | 100% |
| Filing → |
| DBTX | BUY | 2021-02-19 | $2.7M | — | Filing → |
| BCYC | SELL | 2020-09-18 | $151K | — | Filing → |
| GNCA | BUY | 2020-07-30 | $2.8M | — | Filing → |